Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Monkey studies parallel WHI findings, point to importance

26.06.2007
Studies in female monkeys helped raise important questions about hormone therapy that were addressed in a Women’s Health Initiative study reported last week in the New England Journal of Medicine. The animal research, conducted at the Wake Forest University Primate Center, also suggests the role that stress can play in heart disease development and point to the need for early prevention of heart disease.

“Our research in monkeys suggests that stress can affect estrogen levels and may set the stage for heart disease later in life,” according to Jay Kaplan, Ph.D., professor of comparative medicine and director of the primate center. “It also suggests women need to start thinking about heart disease prevention before menopause. We found that the five years before menopause are when heart vessel disease begins to accelerate.”

Kaplan and Thomas Clarkson, D.V.M., have published numerous articles from their monkey research on the effects of hormone therapy on heart vessel disease. Their findings, along with research in humans, were a driving force behind the hypothesis that there is a “window of opportunity” during which hormone therapy can help prevent atherosclerosis. The theory was explored in the Women’s Health Initiative Coronary Artery Calcium Study (WHI-CAC).

WHI-CAC showed that younger postmenopausal women who take estrogen-alone hormone therapy have significantly less building of calcium plaque in their arteries compared to their peers who did not take hormone therapy. The plaque is considered a marker for future risk of atherosclerosis, the buildup of fatty deposits that can lead to heart attacks and strokes.

Clarkson began a study in 1988 funded by the National, Heart Lung and Blood Institute to study how hormone therapy affects heart disease risk in monkeys. He found that estrogen replacement administered to monkeys as soon as they were made surgically menopausal resulted in about a 70 percent inhibition in the progression of coronary artery atherosclerosis.

When treatment with estrogen or estrogen plus progestin was delayed for an equivalent of six years in women, however, there was no benefit. The work led to the hypothesis that estrogen inhibits the development of vessel disease, but may be ineffective, and even harmful, if the disease already exists.

“Clearly hormone therapy isn’t a drug for preventing or treating heart disease,” said Clarkson. “The question is whether, when hormone therapy is used for the treatment of menopausal symptoms, there are benefits associated with the cardiovascular system that might offset any documented risks.”

In addition to raising this important question about hormone therapy, the animal studies also have other important health implications for women. Women have traditionally been considered immune from heart disease until after menopause, when their estrogen levels dramatically drop. But the monkey studies suggest that stress can actually reduce estrogen levels much earlier in life and hasten the development of atherosclerosis, thus increasing the postmenopausal burden of coronary disease risk.

These effects may apply to up to half of premenopausal women, Kaplan said, emphasizing the need for young women to be educated about the relationship between reproductive health and chronic disease risk.

"Our research adds to the growing body of evidence that cardiovascular health after menopause is influenced by hormone levels many years earlier," said Kaplan. "The message for women is that anything that reduces estrogen levels in young adulthood - whether it be stress or exercise and diet habits - may put women on a high-risk course for heart disease."

Clarkson said that because cardiovascular disease is the leading cause of death among women over age 55 – and because studies show that declines in estrogen in perimenopause can lead to its development – it is imperative to identify risk factors and promote early prevention.

“The evidence that levels of atherosclerosis present at the time of menopause are determined by premenopausal estrogen exposure is underappreciated,” he said.

Karen Richardson | EurekAlert!
Further information:
http://www.wfubmc.edu

More articles from Studies and Analyses:

nachricht Researchers simplify tiny structures' construction drip by drip
12.11.2018 | Princeton University, Engineering School

nachricht Mandibular movement monitoring may help improve oral sleep apnea devices
06.11.2018 | Elsevier

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Purdue cancer identity technology makes it easier to find a tumor's 'address'

16.11.2018 | Health and Medicine

Good preparation is half the digestion

16.11.2018 | Life Sciences

Microscope measures muscle weakness

16.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>